MedPath

A study comparing recovery features of patients undergoing general anaesthesia with rocuronium as muscle relaxant and recieving sugammadex or neostigmine and glycopyrollate for reversal.

Phase 4
Conditions
Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangreneHealth Condition 2: K800- Calculus of gallbladder with acutecholecystitisHealth Condition 3: N920- Excessive and frequent menstruation with regular cycle
Registration Number
CTRI/2024/04/065600
Lead Sponsor
Manipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

American Society of Anesthesiologists grades 1, 2, and 3 patients aged 18–60 years, coming for elective laparoscopic surgeries (lasting one to three hours) will be recruited for the study.

Exclusion Criteria

1. Patients with cardiorespiratory abnormalities (New York Heart Association heart failure grades 3 and 4.

2. Known allergy to Rocuronium.

3. Renal insufficiency (eGFR <60).

4. Liver dysfunction (liver enzymes—serum glutamic oxaloacetic transaminase/ serum glutamic pyruvic transaminase values elevated by more than 50% of normal).

•Underlying neuromuscular disease or the use of drugs known to interfere with neuromuscular transmission.

•Intraoperative hypothermia (core temperature less than 35°C).

•Known Emphysema.

•Unwillingless to perform PFT.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time taken for complete reversal of neuromuscular blockTimepoint: Reversal given at TOF count of 2 and time taken to reach TOF ratio 0.9. It is checked at the end of each case at the time of extubation.
Secondary Outcome Measures
NameTimeMethod
To compare post operative respiratory function in terms of PFTTimepoint: PFT to be done in post anaesthesia care unit 20 minute after extubation
© Copyright 2025. All Rights Reserved by MedPath